EUCTR2014-003155-57-GB进行中（未招募）1 期
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled study to investigate the efficacy and safety of 52 weeks treatment with QGE031 s.c. in Asthma Patients not adequately controlled by medium- or high-dose ICS plus LABA with or without OCS
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •A diagnosis of allergic asthma, uncontrolled on current medication.
- •History of at least 2 asthma exacerbations during the last 1 year
- •Forced Expiratory Volume in one second (FEV1) of = 40% and = 80%
- •of the predicted normal value; reversibility following administration of
- •bronchodilator.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 293
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 147
排除标准
- •Use of tobacco products within the previous 6 months (Social occasional smokers may be included).
- •Recent asthma attack/exacerbation or asthma worsening/ respiratory
研究者
相似试验
进行中（未招募）
不适用
Treatment Resistant Depression study for RO4995819MedDRA version: 14.1Level: PTClassification code 10012378Term: DepressionSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 14.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSSystem Organ Class: 10037175 - Psychiatric disordersMajor Depressive DisorderEUCTR2011-002160-24-ATF. Hoffmann-La Roche Ltd.340
进行中（未招募）
1 期
Efficacy, Safety, and Durability of Response of BMS-986165 versus Placebo and Active Comparator in Subjects with PsoriasisEUCTR2018-001925-24-GBBristol-Myers Squibb International Corporation1,000
进行中（未招募）
1 期
Phase 3 trial of PXT3003 in Charcot-Marie-Tooth (CMT) Type 1A patientsCharcot Marie Tooth Type 1AMedDRA version: 20.0Level: LLTClassification code 10008414Term: Charcot-Marie-Tooth diseaseSystem Organ Class: 100000004850EUCTR2020-004805-30-BEPharnext SCA387
进行中（未招募）
不适用
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled 12-week Pilot Exploratory Study to Evaluate the Efficacy and Safety of Teikoku Tulobuterol Tape (6 mg) in Adults with Bronchial AsthmaReversible airways obstruction in patients with AsthmaMedDRA version: 9.1Level: LLTClassification code 10062109Term: Reversible airways obstructionMedDRA version: 9.1Level: LLTClassification code 10006070Term: Br. asthmaEUCTR2007-004886-16-LTTeikoku Pharma USA, Inc.80
进行中（未招募）
1 期
Study to evaluate effectiveness and safety in subjects with moderate to severe PsoriasisEUCTR2016-002481-31-LVBristol-Myers Squibb International Corporation516